Introduction
Alphaviruses are simple, enveloped viruses with a positive-sense RNA genome . The particle is~70 nm in diameter and has three concentric layers: a central nucleocapsid core that consists of the viral genome surrounded by the capsid protein, a host-derived lipid membrane that covers the core, and, on the surface of the particle, 80 trimeric glycoprotein spikes that are embedded in the lipid membrane Mukhopadhyay et al., 2006) .
Alphavirus particle assembly consists of two parallel and independent pathways, nucleocapsid core and glycoprotein spike formation. The two pathways merge during budding, the final stage of virus assembly. The five structural proteins, capsid-E3-E2-6K-E1, are synthesized from a 26s subgenomic mRNA. The capsid protein is autoproteolytically cleaved from the polyprotein during translation (Melancon and Garoff, 1987) . In the cytoplasm, 240 capsid proteins and one progeny genome self-assemble to form a nucleocapsid core. The remainder of the polyprotein, E3-E2-6K-E1, is co-translationally translocated into the ER where it is cleaved into individual proteins. Spikes are assembled in the ER and Golgi, and transported to the plasma membrane via the host cell secretory machinery (Wahlberg et al., 1989; Ziemiecki et al., 1980) . During budding, the nucleocapsid core protrudes through the cell membrane embedded with glycoprotein spikes and a virus particle is released from the cell. It is hypothesized that the interaction between the cytoplasmic tail of the E2 protein and the hydrophobic pocket in the capsid protein aids in assembly and stabilizes the virus particle (Lee et al., 1996; Skoging et al., 1996; Wilkinson et al., 2005; Zhao et al., 1994) . Mutations in the E2 cytoplasmic tail inhibited virus budding and reduced particle formation (Owen and Kuhn, 1997; . While the amino acid sequence of E2 cytoplasmic tails is similar (Lee et al., 1996; Skoging et al., 1996) , chimeric viruses where the glycoproteins are from one alphavirus species and the capsid is from another species, form very low levels of particles compared to the parental viruses (Lopez et al., 1994) . Non-enveloped nucleocapsid cores are not released from cells. The distinct and separable assembly pathways make alphaviruses an attractive system for synthesizing enveloped virus-like particles (VLPs) using in vitro assembled components.
Alphavirus core-like particles (CLPs) have been assembled in vitro by mixing recombinant alphavirus capsid protein and single-stranded nucleic acid (Tellinghuisen et al., 1999) . CLPs can also be assembled using artificial scaffolds such as nanoparticles (Goicochea et al., 2007) and polyanions such as heparin (F. Cheng and S. Mukhopadhyay, unpublished data) . Cryo-electron microscopy and 3D image reconstructions of CLPs containing a DNA oligomer demonstrated that the CLPs are approximately 40 nm in diameter and that the capsid protein subunits within the CLPs are arranged with T = 4 icosahedral symmetry (Mukhopadhyay et al., 2002) : both are characteristics of wild-type nucleocapsid cores. However, previous studies of CLPs did not demonstrate whether or not they could interact with glycoprotein spikes to form VLPs.
In this study, we show that in vitro assembled alphavirus CLPs can associate with alphavirus glycoproteins to form enveloped VLPs. Thus, in vitro assembled CLPs retain the functionality of nucleocapsid core in the absence of any host chaperones. As with native alphaviruses, these in vitro assembled VLPs enter cells via the endocytotic pathway. Furthermore, the VLPs can disassemble and release the contents within the encapsidated CLP. This is the first demonstration that a functional enveloped virus-like particle containing an in vitro assembled core can be synthesized. The ability to make VLPs containing different cargoes in their CLP has significance for basic mechanistic studies of virus assembly as well as drug and nucleic acid delivery and medical imaging applications.
Results and discussion
In vitro core-like particles are assembled using different cargoes Capsid proteins from Sindbis, Western equine encephalitis, and Ross River virus expressed in E. coli have been shown to assemble into CLPs under similar assembly conditions (Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999) . We used the Ross River virus system because full-length capsid protein can be obtained in high yields from a recombinant bacterial expression system, resulting in the reproducible synthesis of higher concentrations of CLPs (Mukhopadhyay et al., 2002) . Furthermore, CLPs can be packaged with a variety of polyanions and both RNA-and DNA-containing CLPs were used in this work. Purified CLPs were homogeneous and approximately 40 nm in diameter like cytoplasmic cores from virus-infected cells and the nucleocapsid core from virus particles (Figs. 1a-c) . Yields of purified CLPs were 30-50% of the starting capsid protein in numerous independent preparations.
Functional alphavirus glycoproteins are synthesized in BHK cells
To create a cell line that transiently expressed surface glycoproteins for enveloping in vitro assembled CLPs, we cloned the gene fragment encoding the wild-type Ross River virus E3-E2-6K-E1 proteins into the pCAGGS DNA vector (pRRV-GP) for transient expression, guided by expression systems previously described (Kondor-Koch et al., 1983; Liljestrom and Garoff, 1991) . As a negative control, pRRV-GP was modified (pRRV-mtGP) so amino acid residues 399-401 of the E2 cytoplasmic tail were mutated from YAL to DDD. The glycoproteins synthesized from pRRV-mtGP should not interact with CLPs because the putative hydrophobic interaction between the E2 cytoplasmic tail and the capsid protein has been disrupted (Owen and Kuhn, 1997; Zhao et al., 1994) . As a second negative control, we cloned the glycoproteins from wild-type Sindbis virus (pSV-GP) into the pCAGGS vector to investigate the specificity of RRV CLPs towards other alphavirus glycoproteins.
BHK cells transfected with either pRRV-GP, pRRV-mtGP, or pSV-GP produced comparable amounts of the E2 protein and its precursor, pE2 (also called p62), as determined by western blot analysis (data not shown). The cellular distribution of glycoproteins from pRRV-GP, pRRVmtGP, and pSV-GP was similar to each other and to virus-infected cells (Fig. 1d ). Cells transfected with pRRV-GP, pRRV-mtGP, and pSV-GP could undergo cell-to-cell fusion under low pH conditions (Chanel-Vos and Kielian, 2004; Hernandez et al., 2003) suggesting the expressed glycoproteins can mediate membrane fusion, whereas mock transfected cells did not form syncytia at any pH tested. These results are consistent with those reported for other alphavirus systems.
Cytoplasmic cores form virus particles with viral glycoproteins produced from pRRV-GP
In virus-infected cells, cytoplasmic nucleocapsid cores contain the viral genome. Initially we investigated whether or not we could form infectious particles by transfecting purified cytoplasmic cores into cells expressing viral glycoproteins from pRRV-GP. This approach used assembly components most similar to those found in a virus infection.
We transfected 18 μg, or 1.6 × 10 12 purified cytoplasmic nucleocapsid cores from Ross River virus-infected cells into 1.4 × 10 7 BHK cells previously transfected with pRRV-GP or into 1.4 × 10 7 non-transfected BHK control cells. After 1 h cells were washed and after an additional hour incubated in fresh medium, the latter was collected and assayed for infectious particles. The short incubation time minimized the chance of genome replication and virus assembly from a disassembled cytoplasmic core. There were 300-600 pfu (~10 2 pfu/ml) from pRRV-GPtransfected cells. In contrast, no infectious particles were isolated from BHK control cells. This indicates that cytoplasmic cores by themselves did not disassemble and could not propagate infections in our time frame. The low titer of the infectious virus likely reflects a combination of low transfection efficiency of cytoplasmic cores, the limited transport of cytoplasmic cores to the appropriate membrane for packaging, and the short time period over which we collected particles. Nevertheless, these results show that cells transfected with cytoplasmic cores can generate infectious virus particles.
Optimizing the strategy for generating VLPs
We sought to determine whether in vitro assembled Ross River CLPs could associate with Ross River glycoproteins expressed in trans to form VLPs. We first needed to determine the timing of the transfection of CLPs into BHK cells and timing of particle budding. Transfection is highly dependent on the size of the entering particle and its surface charge. Although transfection has been successfully used with cores of other viral systems (Bichko et al., 1994; Jiang and Coombs, 2005) , it has not been previously reported for alphavirus nucleocapsid cores. We determined CLP transfection by monitoring the presence of capsid protein in newly transfected cells. We transfected 3 μg CLPs containing 48mer DNA (~2.6× 10 11 CLPs) into 2.4 × 10 6 non-transfected BHK control cells using Lipofectamine 2000 as used with other virus systems. At various times post-transfection, the cells were washed and lysed, and the lysates were then probed for capsid protein by western blotting (Fig. 2a) . The capsid protein in these cells would be from the CLPs that were transfected into them. The presence of capsid protein was detected within 15 min post-transfection and reached a maximum at 30-60 min post-transfection. Levels of capsid protein started to decrease only after 4 h. The stability of the capsid protein suggests that CLPs are not immediately disassembling because during a native alphavirus infection, the nucleocapsid core disassembles under acidic conditions within 2 min of entry into the cytoplasm (Wengler, 2009; Wengler and Wengler, 2002) . However, in these transfection assays, CLPs enter the cytoplasm directly and bypass the endosome (Jiang and Coombs, 2005) . We hypothesized that the timing of virus-like particle budding would be different than during a native alphavirus infection because during production of VLPs, the core was already assembled and ready to bud. To determine the timing of potential VLPs being released into the media, we assayed the medium for the presence of capsid protein as an indicator of VLPs. We transfected 19 μg CLPs containing 48mer DNA (~1.6 × 10 12 CLPs) into 1.4 × 10 7 BHK cells expressing pRRV-GP. One hour post-CLP transfection, cells were washed and fresh medium was added; this is defined as zero time. Medium from the cells was collected at 30, 60, and 120 min and centrifuged. Thus, medium collected at 30 min contains particles released between 0 and 30 min, medium collected at 60 min contains particles released between 30 and 60 min, and medium collected at 120 min contains particles released between 60 and 120 min. After centrifugation, each sample was analyzed for the presence of capsid protein ( Fig. 2b ). At t = 0 no capsid protein was detected indicating that non-transfected CLPs were completely removed during the wash step: all capsid protein detected subsequently is therefore from released VLPs. We could detect capsid protein in the pelleted particles at 30 min but between 30 and 60 min (time 60 min), much less capsid protein was detected. These results indicate that viruslike particle assembly and release was complete within 30 min of addition of the fresh medium. One explanation for this narrow time range for VLP production is that there is a finite number of CLPs inside the viral glycoprotein-expressing cell. Once all the CLPs form into VLPs, no more particles can be formed. In contrast, during a viral infection cytoplasmic cores are continuously being synthesized so virus particles are continuously being released from over a long period of time.
In a viral infection, genome replication and structural protein synthesis occur before particle release. Particles are first detected 4 to 6 h post-infection and continue to be released until 12 to 15 h postinfection. In our assays, VLPs are produced much earlier than virus particles are produced during an infection. When we transfect CLPs, we are presumably initiating assembly at the last steps of budding when the nucleocapsid cores interact with the glycoproteins and were able to form virus particles more quickly. The amount of VLPs released depends upon the amount of CLPs that have been transfected since new CLPs are not being synthesized within the cell.
Taking into account the above observations, we standardized our protocol for making VLPs. Transfect BHK cells with pRRV-GP and, 15 h later when glycoprotein synthesis was occurring, transfect purified CLPs into the same cells. After 1 h, the medium was removed, cells were washed with PBS to remove non-transfected CLPs, and fresh medium was added. After an additional one hour incubation the medium was collected and analyzed for VLPs. This timing was used for two reasons. First, optimal yield of VLPs was obtained one hour post-CLP transfection (as determined by western blot). Second, if we collected all the medium post-CLP transfection and did not wash the cells, non-transfected CLPs remaining in the medium would interfere with quantitation and characterization of the VLPs. As a consequence of the timing of our assays, we may be underestimating the amount of VLPs that are formed. Hypothetically, if CLPs enter the cell within 30 min and can bud and be released within 15 min, these VLPs would not be collected in our assays.
VLPs contain viral glycoproteins and capsid protein
Our small scale optimization results, obtained by transfecting CLPs into BHK cells expressing pRRV-GP, demonstrated that VLPs were released into the media (Fig. 2b) . We wanted to determine if the viral glycoproteins were also present in the VLPs. We transfected 90 μg CLPs containing 48mer DNA (~7.8 × 10 12 CLPs) into 7.2 × 10 7 BHK cells expressing pRRV-GP and into 7.2 × 10 7 non-transfected BHK control cells. The medium from each sample (after the appropriate washes) was applied to a sucrose cushion and centrifuged. The pellets from pRRV-GP plus CLPs transfection contained both E2 and capsid protein as determined by western blot (Fig. 3a, lane 4) . In contrast, resuspended pellets from CLPs transfected into control BHK cells contained neither E2 nor capsid protein (Fig. 3a, lane 3) . This result is consistent with our hypothesis that VLPs only form in the presence of CLPs and viral glycoproteins. In addition, it also demonstrated that non-transfected CLPs were removed during the wash step. As a positive control, Ross River virus was pelleted and 1.5 × 10 8 particles were loaded on the gel (Fig. 3a, lane 2 ).
Virus-like particle formation requires E2-capsid interaction
The interaction between the cytoplasmic tail of the E2 protein and the hydrophobic pocket of the capsid protein promotes virus budding. We abolished this interaction when expressing an E2 mutant (pRRVmtGP) in which residues in the cytoplasmic tail were mutated from YAL to DDD. Glycoprotein expression and syncytia formation for pRRV-mGP were comparable to cells expressing pRRV-GP and virusinfected cells (Fig. 1d) . However when 108 μg of CLPs containing 48mer DNA oligomer (~9.3 × 10 12 CLPs) was transfected into 7.2 × 10 7 BHK cells expressing pRRV-mtGP, neither E2 nor capsid protein was detected in the resuspended pellet (Fig. 3b) . If any VLPs formed with the mutant glycoprotein pRRV-mtGP, their amounts were severely reduced in comparison to those formed using pRRV-GP. When the YAL-NDDD mutation was made in Ross River virus, no infectious particles were detected in plaque assays. Thus, VLPs contain E2 and capsid protein, and show an E2-capsid protein-dependent interaction.
VLPs are morphologically similar to native virus particles
We wanted to determine if the morphology and size of the VLPs were similar to the native alphavirus particles. When viewed by transmission electron microscope (TEM), the resuspended pellet from the pRRV-GP plus CLPs transfected cells show spherical particles with a diameter of approximately 70 nm by electron microscopy (Fig. 4a) , consistent with native alphavirus particles. The number of VLP observed was fewer than from a native infection. However, the distribution of particle size and variation in particle shape were similar to what is observed when we pelleted native virus. Some particles look less spherical in both the VLP and native virus population and we speculate that this is due to pelleting virus particles. No unenveloped CLPs (40 nm diameter, spherical particles) were observed. No spherical particles with either 70 or 40 nm diameter were found in the resuspended pellet from the control experiment where CLPs transfected into non-viral glycoprotein expressing cells. The absence of both virus-like and core-like particles in this control was consistent with a western blot of the media (Fig. 3a) .
Cryo EM structures of both in vitro assembled CLPs (Mukhopadhyay et al., 2002) and isolated cytoplasmic nucleocapsid cores (Lamb et al., 2010) indicate that these complexes are flexible and undergo glycoprotein-mediated conformation changes. From negative stain TEM images, it was difficult to determine if the glycoprotein spikes were fully covering the CLP. To determine if there were areas on the VLP that were not surrounded by the spikes, thus the capsid proteins were exposed, we assayed resuspended VLP pellets with anti-capsid protein antibody. The rationale was if the glycoprotein spikes were not covering the CLP then the VLP would be immunoprecipitated using an anti-capsid antibody. However, if the CLP was covered by glycoprotein spikes, as is observed in native virus particles, then the VLPs would not bind to the capsid antibody. Here, 20 μg of CLPs containing 48mer DNA (~1.7 × 10 12 CLPs) was transfected into 1.4 × 10 7 BHK cells, both those expressing RRV-GP and control cells not expressing viral glycoproteins. Concentrated VLPs were immunoprecipitated with anti-capsid antibody and then analyzed by western blotting. No VLPs could be detected in the medium from RRV-GP plus CLPs transfected cells indicating large areas of capsid protein in the CLP was not surface exposed (Fig. 4b, lane 3) . A strong capsid protein band was detected when we directly added 15 μg (~1.2 × 10 12 particles) CLPs to the medium, pelleted the CLPs, and immunoprecipitated the resuspended pellet with anti-capsid antibody (Fig. 4b, lane 6) . The absence of detectable capsid protein in medium from CLPs transfected into control BHK cells (Fig. 4b , lane 2) demonstrated that secretion of VLPs requires glycoproteins, consistent with native alphavirus particles.
VLPs can enter and disassemble in cells
We tested the entry and disassembly activity of our VLPs by creating particles that contain luciferase RNA reporter. We synthesized VLPs from CLPs containing luciferase RNA, 18 μg CLPs transfected into 1.4 × 10 7 BHK cells transfected with RRV-GP or into non-transfected BHK control cells. Medium containing the VLPs (total volume = 3 ml) was incubated with 2.4 × 10 6 BHK cells. After 12 h, cells were lysed and assayed for luciferase activity. This incubation is intended to mimic an infection; no transfection reagent was included. Luciferase would only be translated if the VLPs could enter and disassemble within the new cell. Within each set of experiments, the luciferase activity detected from BHK cells that were incubated with medium from pRRV-GP plus CLP-transfected cells was set to 1 (Fig. 5a ). Cells that were incubated with medium from CLPs transfected into BHK control cells had background levels of luminescence (Fig. 5a ). Alphaviruses have been reported to enter the host cells either via receptor-mediated endocytosis (Bron et al., 1993; Marsh et al., 1984) . Entry at neutral pH at the plasma membrane has also been reported (Paredes et al., 2004) . We specifically tested the hypothesis that VLPs entered BHK cells using the same route as Ross River virus. We blocked the entry using a neutralizing antibody and inhibiting pH change in the endosome.
The epitope of the Ross River neutralizing antibody T10C9 is the receptor-binding domain of the E2 protein Vrati et al., 1988) . When 3 ml of medium containing VLPs made with luciferase CLPs was incubated with 500 μl of T10C9 antibody in serum, the luciferase activity in the incubated BHK cells was reduced by 50% compared to VLPs not treated with the neutralizing antibody. These results demonstrate that an E2-specific neutralizing antibody is able to interfere with virus-like particle entry into host cells, consistent with what is observed with native Ross River virus (Vrati et al., 1988) (Fig. 5b) .
When BHK cells were pre-treated with NH 4 Cl and then infected with Ross River virus, we observed a decrease in titer from 10 8 to 10 5 pfu/ml (Fig. 5b) as previously reported for other alphaviruses (GlombReinmund and Kielian, 1998; Helenius et al., 1982) . Similarly, VLPs showed reduced luminescence in BHK cells that had been pre-treated with NH 4 Cl; the luciferase activity was reduced by 70% suggesting that VLP entry occurs via the endosomal pathway, where either fusion and/ or core disassembly may be affected by the change in pH of the NH 4 Clincubated cell. When blocking entry of the VLPs, the luciferase activity of the cells is decreased compared to untreated VLPs but still remains higher than the background CLP luminescence value (Fig. 5a, CLP) . Possible explanations could include that some VLPs do not enter cells via the receptormediated endosomal pathway or the arrangement of the spikes around the particle does not allow for complete neutralization by the T10C9 antibody. In Ross River virus treated with antibody and pre-treatment of cells with NH 4 Cl, there was only a partial decrease in viral titer which correlates with our luciferase assay results (Fig. 5b ). An alternative explanation for the luciferase activities not return to background levels is the CLP may be enveloped by any viral glycoprotein-containing membrane and, as a result, particles may show increased luminescence in cells. To test this hypothesis, we transfected 3.6 μg (~3.1×10
11 CLPs) made with Ross River capsid protein into 2.4 × 10 6 BHK cells expressing
Sindbis virus glycoproteins, pSV-GP. After the appropriate washes, medium was collected and added to 2.4 × 10 6 BHK cells. Here, the luminescence of cells treated with medium from the RRV CLP + SV-GP VLPs was equal to background levels. Previous reports have demonstrated that chimera viruses where the Ross River capsid protein was exchanged with a Sindbis capsid protein in a Ross River background, or the Sindbis capsid protein was exchanged with a Ross River capsid protein in a Sindbis background (Lopez et al., 1994) , grew very poorly or 10 3 pfu/ml (Fig. 5b) . Our low levels of luciferase activity are consistent with these results and suggest that VLPs are not being formed when Ross River CLPs are transfected into pSV-GP cells.
Concluding remarks
Animal viruses have natural and efficient entry mechanisms making them ideal vector systems for real-time imaging and drug delivery. However, potential dangerous effects due to the presence of the parental virus genome are concerns. In the alphavirus based VLPs, the cell entry properties associated with the glycoprotein spikes are retained but the genome and its pathogenic effects are eliminated because the cargo within the CLP is not specific to the viral genome. We have demonstrated that VLPs can enter and disassemble within a new host cell and there is a strong correlation between the biological activity of VLPs as determined by luciferase activity and virus infectivity as determined by plaque assay. We can expand our work with Ross River VLPs to generate other alphavirus VLPs, extending specificity and cell targeting. Many alphavirus capsid proteins form CLPs using nucleic acid (Hong et al., 2006; Mukhopadhyay et al., 2002; Tellinghuisen and Kuhn, 2000; Tellinghuisen et al., 1999 Tellinghuisen et al., , 2001 ). In addition, CLP formation using inorganic cargoes towards medical imaging has also been demonstrated (Goicochea et al., 2007) . It has been demonstrated in mice that Sindbis viral vectors specifically infect tumors because the virus particles bind to overexpressed laminin receptor synthesized in many tumors (Scheiman et al., 2010; Tseng et al., 2004) , suggesting oncolytic potential for this system (Scheiman et al., 2010; Tseng et al., 2004 ).
The enveloped VLP system provides a means to deliver toxic and labile cargoes. Toxic cargoes will only be released once the VLPs enter the target cell. Similarly, labile cargoes are protected until they are inside the target cell. Applications using VLPs include intracellular delivery of small molecule drugs, siRNAs of modulation of gene expression, and nanoparticles for imaging. The VLP system will require further optimization for maximum production of VLPs and that may be specific to the cargo of the CLP. Our results demonstrate the first steps in the use of alphavirus nanoparticles in basic mechanistic virology studies as well as in application-driven uses of the VLPs.
Materials and methods

Viruses and cells
The T48 strain of Ross River virus (Kuhn et al., 1991) was used in this work. BHK-21 cells (American Type Tissue Culture, Rockville, MD) were grown in minimal essential medium (MEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville, GA), non-essential amino acids, glutamine, and penicillin/ streptomycin. Cells were grown at 37°C in the presence of 5% CO 2 . The neutralizing Ross River antibody, T10C9, was generously provided by Richard Kuhn, Purdue University.
Transient expression of alphavirus glycoproteins
The viral glycoproteins E3-E2-6K-E1 from Ross River virus were cloned into a pCAGGS vector; pRRV-GP. A mutant of RRV-GP where amino acid residues E2-399-401 are mutated from YAL to DDD was created by Quick Change mutagenesis (Stratagene, La Jolla, CA); pRRV-mtGP. The viral glycoproteins E3-E2-6K-E1 from Sindbis virus were cloned into a pCAGGS vector; pSV-GP. BHK cells were transfected with pRRV-GP/pRRV-mtGP/pSV-GP using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions. Viral glycoprotein expression was determined by western blotting of cell lysates and immunofluorescence assays using a polyclonal Ross River E2 or Sindbis E2 antibody (Cocalico, Reamstown, PA), and FITC-or TRITC-conjugated goat anti-rabbit secondary antibody.
Syncytia assays
Syncytia assays were performed to determine if cells expressing pRRV-GP, pRRV-mtGP, and pSV-GP were able to mediate fusion. BHK cells were transfected with pRRV-GP, pRRV-mtGP, or pSV-GP using Lipofectamine 2000 (Invitrogen). After 15 h, cells were treated with 200 μl MEM with 20 mM HEPES or 20 mM MES at the specified pH (ranging from pH 7.5 to 5) for 3 min at 37°C. The medium was removed, MEM plus 10% FBS was added, and the cells were incubated for an additional 1 h at 37°C. Syncytia were clearly visible under bright field.
Isolation of cytoplasmic cores from virus-infected cells
Cytoplasmic cores were isolated as described previously (Lopez et al., 1994) . Briefly, BHK cells were infected at MOI = 5 with Ross River virus and 18 h post-infection cytoplasmic cores were harvested in 10 mM Tris (pH 7.5), 10 mM NaCl, and 20 mM EDTA. Lysed cells were incubated on ice for 20 min and then Triton X-100 was added to a final concentration of 3%. Cells were vortexed gently and then centrifuged at 4000 ×g for 10 min at 4°C. Lysates were loaded on a 0-50% sucrose gradient prepared in 20 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, and 0.1% TX-100 and centrifuged in a SW41 rotor at 178,000 ×g for 90 min at 12°C (Lopez et al., 1994) . The fraction containing the nucleocapsid cores was concentrated and buffer-exchanged into PBS. Bradford assays were used to determine the concentration of the cytoplasmic cores. In vitro assembly of core-like particles Ross River capsid protein was cloned into a pET 29b vector (Novagen, EMD Chemical Inc., Gibbstown, NJ) and expressed in Rosetta 2 cells (Novagen, EMD Chemical Inc.). Capsid protein purification was performed as described previously (Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999) . Ross River capsid protein was concentrated and buffer exchanged into 20 mM HEPES, 150 mM NaCl, and 0.1 mM EDTA for use in CLP reactions. For composition and morphology studies, the nucleic acid cargo was a 48mer DNA oligomer (5′-CCGTTAATGCATGTCGAGATATAAAGCATAAGGGACATGC ATTAACGG-3′) (IDT, Coralville, IA). For the cell entry and disassembly studies firefly luciferase mRNA was the cargo (Nickens and Hardy, 2008) . Capped and polyadenylated luciferase mRNA was generated by in vitro transcription using SP6 polymerase and standard reaction components (Nickens and Hardy, 2008) , and was purified using an RNeasy Mini Kit (Qiagen, Valencia, CA). Concentrations of DNA and RNA were determined using a NanoDrop 1000 (Thermo Scientific, Wilmington, DE).
Ross River CLPs were assembled in vitro by incubating 100 μg capsid protein and 60 μg of nucleic acid (either DNA or RNA) at room temperature for 10 min. CLPs were purified to remove residual capsid protein and nucleic acid by applying the reaction mixture onto a 27% sucrose cushion (10 ml) and centrifuging at 130,000 ×g for 2.5 h at 4°C. The pellet was resuspended in PBS to give a protein concentration between 0.30 and 0.45 mg/ml as determined by a Bradford assay. CLP purification yield was 35-50% of starting capsid protein. CLP formation, both before and after concentration, was verified by an agarose gel shift assay and by TEM analysis (Mukhopadhyay et al., 2002; Tellinghuisen et al., 1999) .
Assembly of VLPs with CLPs
The general procedure to assemble VLPs is described below. The total amount of CLPs and the number of cells used were adjusted based on the experiment being conducted and the amount of VLPs needed for analysis. However, the CLP:BHK cell ratio remained similar. In most experiments, the amount of CLPs and cells used is indicated in the text. A 35 mm dish containing 2 × 10 6 BHK cells was transfected with pRRV-GP.
Fifteen hours later, 3 μg of purified CLPs (approximately 2.6 × 10 11 particles) was transfected into the pRRV-GP-transfected cells using 10 μl of Lipofectamine 2000. After 1 h, cells were washed three times with PBS to remove residual CLPs and Lipofectamine reagent and 0.5 ml of MEM + 10% FBS were added to the cells. After one additional hour, the medium which contains VLPs was collected. We tested several transfection agents for transfecting CLPs including Lipofectamine 2000 (Invitrogen), Fugene 6 (Roche), and PEI (Sigma). In addition we tested reagents specific for protein and peptide transfection, including Chariot (Motif Active), and microinjection and syringe loading (Clarke and McNeil, 1992) of CLPs. Lipofectamine 2000 yielded the highest efficiency of transfection.
Concentrating VLPs
VLPs were concentrated for western blot and TEM studies. Medium containing VLPs was filtered through a 0.45 μm syringe filter to remove cells and cell debris. The medium was applied onto a 27% sucrose cushion (10 ml) and centrifuged at 130,000 ×g for 2.5 h at 4°C. The pellet, which contains the VLPs, was resuspended in PBS to yield~0.15 mg/ml of VLPs based on protein concentration.
Western blot and immunoprecipitation of VLPs
To determine the composition of VLPs, 10 μl of the resuspended VLPs was analyzed by SDS-PAGE and probed for RRV capsid and E2 protein using polyclonal antibodies. For immunoprecipitation experiments, anti-capsid protein antibodies were coupled to the agarose coupling resin columns of a ProFound Co-Immunoprecipitation Kit (Pierce, Rockford, IL) according to the manufacturer's protocol. As a control for non-specific binding of CLPs/protein to the agarose beads, a sample not including antibody was also performed. Ten microliters of the resuspended VLPs was incubated with the agarose beads (+/−antibody) at room temperature for 2 h. Samples were eluted from the column by SDS and analyzed by western blotting.
Transmission electron microscopy
Samples of concentrated VLPs (3-5 μl) were applied to 400-mesh carbon-coated formvar copper grids and stained with 1% uranyl acetate. The grids were examined on a JEOL 1010 transmission electron microscope (Tokyo, Japan) at 80 kV. Images were recorded using a Gatan UltraScan 4000 CCD camera (Pleasanton, CA).
Luciferase assay
VLPs containing luciferase RNA were added to cells to determine if they were capable of entering and disassembling within a cell. Medium containing VLPs from 6 to 35 mm dishes was collected (total volume = 3 ml) and incubated with 2.4 × 10 6 BHK cells. After 12 h, luciferase assays were performed using a Luciferase Assay Kit (Sigma, St. Louis, MO) according to the manufacturer's directions. Cells were lysed in 150 μl lysis buffer. Samples were measured using a BIO-TEK synergy HT multimode microplate reader (BIO-TEK, Winooski, VT). Samples were measured in triplicate and at least six experiments were averaged for each sample. The range of luminescence minimum and maximum between experiments varied even though the relative values within an experiment were consistent. The absolute luminescence values were normalized for each experiment. To do so, background values determined from BHK cell lysates were subtracted from all samples. Within each set of experiments, luminescence from particles isolated from cells expressing RRV-GP that had been transfected with CLPs (medium containing VLPs) was set to 1. Standard error was determined between sets of experiments.
Treatment of VLPs and virus with neutralizing antibody
Three milliliters of medium containing VLPs was incubated with 500 μl T10C9 antibody in serum for 30 min at room temperature. The mixture was applied to BHK cells and after 12 h luciferase activity was determined as described above. One milliliter of wild-type Ross River virus was incubated with 500 ml of T10C9 antibody for 30 min at room temperature. Infectivity was determined by plaque assay.
Treatment of cells with ammonium chloride
BHK cells were pre-treated with 20 mM freshly prepared ammonium chloride for 20 min before being incubated with 3 ml of VLPs. After 1 h of incubation, the medium containing the particles was removed and fresh medium containing 20 mM ammonium chloride was added. After 12 h, cell lysates were assayed for luciferase activity. Infectivity of Ross River virus was determined in a similar manner. Cells were pre-treated with 20 mM NH 4 Cl for 20 min before being infected with Ross River virus. After 24 h, the medium from virus-incubated cells was removed and titered.
